Ziqi Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ziqi Liu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Leihong Xiang
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China
5 shared publications - Chengfeng Zhang
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, PR China
4 shared publications - Yiwen Yang
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China
3 shared publications - Yue Wu
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China
3 shared publications - Yi Lin
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, PR China
2 shared publications - Yuecen Ding
Department of Dermatology, Huashan Hospital Fudan University Shanghai China
2 shared publications
Latest Publications
- 27 January 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (7) , 1887-1895.e7
Clinical characteristics, outcome, and costs among patients in a dermatological intensive care unit: A single-center retrospective study
- 27 January 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (7) , 1887-1895.e7
Clinical characteristics, outcome, and costs among patients in a dermatological intensive care unit: A single-center retrospective study
- 28 March 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (6) , 1083-1089
Persistent exanthema mainly on the trunk with pathologically dermal interstitial mucin as anti‐ HMGCR myopathy‐associated skin rash: Case series
Antibodies to 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) form a newly identified distinct serological marker for necrotizing autoimmune myopathy. Although anti‐HMGCR myopathy is currently classified into polymyositis, skin involvement has been reported, with its characteristics only vaguely described. We retrospectively examined the clinical and histological features of non‐dermatomyositis‐like persistent exanthema in five anti‐HMGCR myopathy patients followed up in the neurology and dermatology clinic of Huashan Hospital between December 2020 and September 2024. The exanthema presented as persistent violaceous or erythematous plaques, asymptomatic or itching, mainly distributed on the trunk, whereas dermatomyositis‐specific lesions such as Gottron's sign and papules, heliotrope rash, V or shawl signs, and nailfold telangiectasia were all absent. Skin rash in 80% of patients (4/5) appeared earlier than muscle symptoms such as fatigue, proximal limb weakness, and hyperCKemia, with the median advanced time of 3 years (8 months to 7 years). Biopsies revealed scant interface dermatitis, interstitial mucin, and perivascular lymphocytic infiltrate with occasionally plasma cells and/or neutrophils. Notably, the exanthema showed no response to topical or even systemic corticosteroid but relieved after systemic immunosuppressive therapy for myopathy, in accordance with the improvement of muscle symptoms and hyperCKemia. Dermatologists should be aware of this rare entity of “pseudo‐dermatomyositis”, carefully evaluate muscle syndromes and carry out further investigations, including muscle biopsy and serum anti‐HMGCR antibodies assays if present.
- 28 March 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (6) , 1083-1089
Persistent exanthema mainly on the trunk with pathologically dermal interstitial mucin as anti‐ HMGCR myopathy‐associated skin rash: Case series
Antibodies to 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) form a newly identified distinct serological marker for necrotizing autoimmune myopathy. Although anti‐HMGCR myopathy is currently classified into polymyositis, skin involvement has been reported, with its characteristics only vaguely described. We retrospectively examined the clinical and histological features of non‐dermatomyositis‐like persistent exanthema in five anti‐HMGCR myopathy patients followed up in the neurology and dermatology clinic of Huashan Hospital between December 2020 and September 2024. The exanthema presented as persistent violaceous or erythematous plaques, asymptomatic or itching, mainly distributed on the trunk, whereas dermatomyositis‐specific lesions such as Gottron's sign and papules, heliotrope rash, V or shawl signs, and nailfold telangiectasia were all absent. Skin rash in 80% of patients (4/5) appeared earlier than muscle symptoms such as fatigue, proximal limb weakness, and hyperCKemia, with the median advanced time of 3 years (8 months to 7 years). Biopsies revealed scant interface dermatitis, interstitial mucin, and perivascular lymphocytic infiltrate with occasionally plasma cells and/or neutrophils. Notably, the exanthema showed no response to topical or even systemic corticosteroid but relieved after systemic immunosuppressive therapy for myopathy, in accordance with the improvement of muscle symptoms and hyperCKemia. Dermatologists should be aware of this rare entity of “pseudo‐dermatomyositis”, carefully evaluate muscle syndromes and carry out further investigations, including muscle biopsy and serum anti‐HMGCR antibodies assays if present.
- 9 September 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (4) , 751-753
A case of recalcitrant folliculotropic mycosis fungoides successfully treated by abrocitinib
- 9 September 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (4) , 751-753
A case of recalcitrant folliculotropic mycosis fungoides successfully treated by abrocitinib
- Open Access
- 1 September 2024
- Published by American Physiological Society in Advances in Physiology Education
- Vol. 48 (3) , 446-454
A partially flipped physiology classroom improves the deep learning approach of medical students
In this article, we compare the impact of the partially flipped classroom (PFC) and the traditional lecture classroom (TLC) in a physiology course on medical students’ learning approaches. We found that the PFC benefited students by significantly enhancing their deep learning motive, strategy, and approach, which was good for them. However, the TLC model only improved the surface learning motive and approach.
- 1 September 2024
- Published by American Physiological Society in Advances in Physiology Education
- Vol. 48 (3) , 446-454
Open AccessA partially flipped physiology classroom improves the deep learning approach of medical students
In this article, we compare the impact of the partially flipped classroom (PFC) and the traditional lecture classroom (TLC) in a physiology course on medical students’ learning approaches. We found that the PFC benefited students by significantly enhancing their deep learning motive, strategy, and approach, which was good for them. However, the TLC model only improved the surface learning motive and approach.
- 15 March 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (8) , 1696-1706
Emerging Role of Fibroblasts in Vitiligo: A Formerly Underestimated Rising Star
- 15 March 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (8) , 1696-1706
Emerging Role of Fibroblasts in Vitiligo: A Formerly Underestimated Rising Star
- 20 June 2023
- Published by Wiley in Experimental Dermatology
- Vol. 33 (1)
The underestimated role of mitochondria in vitiligo: From oxidative stress to inflammation and cell death
Vitiligo is an acquired depigmentary disorder characterized by the depletion of melanocytes in the skin. Mitochondria shoulder multiple functions in cells, such as production of ATP, maintenance of redox balance, initiation of inflammation and regulation of cell death. Increasing evidence has implicated the involvement of mitochondria in the pathogenesis of vitiligo. Mitochondria alteration will cause the abnormalities of mitochondria functions mentioned above, ultimately leading to melanocyte loss through various cell death modes. Nuclear factor erythroid 2‐related factor 2 (Nrf2) plays a critical role in mitochondrial homeostasis, and the downregulation of Nrf2 in vitiligo may correlate with mitochondria damage, making both mitochondria and Nrf2 promising targets in treatment of vitiligo. In this review, we aim to discuss the alterations of mitochondria and its role in the pathogenesis of vitiligo.
- 20 June 2023
- Published by Wiley in Experimental Dermatology
- Vol. 33 (1)
The underestimated role of mitochondria in vitiligo: From oxidative stress to inflammation and cell death
Vitiligo is an acquired depigmentary disorder characterized by the depletion of melanocytes in the skin. Mitochondria shoulder multiple functions in cells, such as production of ATP, maintenance of redox balance, initiation of inflammation and regulation of cell death. Increasing evidence has implicated the involvement of mitochondria in the pathogenesis of vitiligo. Mitochondria alteration will cause the abnormalities of mitochondria functions mentioned above, ultimately leading to melanocyte loss through various cell death modes. Nuclear factor erythroid 2‐related factor 2 (Nrf2) plays a critical role in mitochondrial homeostasis, and the downregulation of Nrf2 in vitiligo may correlate with mitochondria damage, making both mitochondria and Nrf2 promising targets in treatment of vitiligo. In this review, we aim to discuss the alterations of mitochondria and its role in the pathogenesis of vitiligo.
- 4 January 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (9) , 2950-2962
Dynamic evaluation of an in vivo postinflammatory hyperpigmentation model using reflectance confocal microscopy and spectrophotometry
Background Post‐inflammatory hyperpigmentation (PIH) reflects a dynamic process from primary injury and cutaneous inflammation to subsequent melanogenesis and hyperpigmentation, of which pathogenesis remains unclear, hindering the development of targeted therapies. Aims To observe the dynamic development of PIH; determine the starting point and peak point of the inflammatory phase and pigmentary phase; clarify the timing of anti‐inflammatory and anti‐pigmentary treatment. Methods Thirty healthy volunteers with Fitzpatrick skin types III‐IV were enrolled and underwent suction blisters. The non‐invasive evaluation of inflammation and hyperpigmentation on suction‐blister sites were performed via spectrophotometry (CM2600d and SIAscope) and RCM for the following 24 weeks. Results We successfully observed suction blister‐induced PIH lasting over 24 weeks. The inflammatory phase started soon after the procedure and lasted for 8‐12 weeks, manifested by significantly elevated a* values and erythema index detected by spectrophotometry, as well as inflammatory infiltration and angiogenesis shown in RCM images. Meanwhile, melanogenesis was accelerated after week 3 and reached peek on week 8, manifested by significantly accumulated melanin granules and bright pigment rings in different depths under RCM, which was in parallel with elevated melanin index. The darkening skin tone in PIH actually presented a mixture of inflammatory erythema, angiogenesis and hyperpigmentation. The inflammation and pigmentation phases of PIH were not sequential but partially overlap. Conclusion The duration of suction blister induced‐PIH is more than 24 weeks. The inflammatory phase partially overlaps with the pigmentary phase, and those drugs with anti‐inflammatory and anti‐pigmentary dual effects are potential choices.
- 4 January 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (9) , 2950-2962
Dynamic evaluation of an in vivo postinflammatory hyperpigmentation model using reflectance confocal microscopy and spectrophotometry
Background Post‐inflammatory hyperpigmentation (PIH) reflects a dynamic process from primary injury and cutaneous inflammation to subsequent melanogenesis and hyperpigmentation, of which pathogenesis remains unclear, hindering the development of targeted therapies. Aims To observe the dynamic development of PIH; determine the starting point and peak point of the inflammatory phase and pigmentary phase; clarify the timing of anti‐inflammatory and anti‐pigmentary treatment. Methods Thirty healthy volunteers with Fitzpatrick skin types III‐IV were enrolled and underwent suction blisters. The non‐invasive evaluation of inflammation and hyperpigmentation on suction‐blister sites were performed via spectrophotometry (CM2600d and SIAscope) and RCM for the following 24 weeks. Results We successfully observed suction blister‐induced PIH lasting over 24 weeks. The inflammatory phase started soon after the procedure and lasted for 8‐12 weeks, manifested by significantly elevated a* values and erythema index detected by spectrophotometry, as well as inflammatory infiltration and angiogenesis shown in RCM images. Meanwhile, melanogenesis was accelerated after week 3 and reached peek on week 8, manifested by significantly accumulated melanin granules and bright pigment rings in different depths under RCM, which was in parallel with elevated melanin index. The darkening skin tone in PIH actually presented a mixture of inflammatory erythema, angiogenesis and hyperpigmentation. The inflammation and pigmentation phases of PIH were not sequential but partially overlap. Conclusion The duration of suction blister induced‐PIH is more than 24 weeks. The inflammatory phase partially overlaps with the pigmentary phase, and those drugs with anti‐inflammatory and anti‐pigmentary dual effects are potential choices.